2005 related articles for article (PubMed ID: 14737169)
1. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1.
Matloubian M; Lo CG; Cinamon G; Lesneski MJ; Xu Y; Brinkmann V; Allende ML; Proia RL; Cyster JG
Nature; 2004 Jan; 427(6972):355-60. PubMed ID: 14737169
[TBL] [Abstract][Full Text] [Related]
2. Finding a way out: lymphocyte egress from lymphoid organs.
Schwab SR; Cyster JG
Nat Immunol; 2007 Dec; 8(12):1295-301. PubMed ID: 18026082
[TBL] [Abstract][Full Text] [Related]
3. Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus.
Chiba K; Matsuyuki H; Maeda Y; Sugahara K
Cell Mol Immunol; 2006 Feb; 3(1):11-9. PubMed ID: 16549044
[TBL] [Abstract][Full Text] [Related]
4. Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow.
Maeda Y; Seki N; Sato N; Sugahara K; Chiba K
Int Immunol; 2010 Jun; 22(6):515-25. PubMed ID: 20497959
[TBL] [Abstract][Full Text] [Related]
5. CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs.
Shiow LR; Rosen DB; Brdicková N; Xu Y; An J; Lanier LL; Cyster JG; Matloubian M
Nature; 2006 Mar; 440(7083):540-4. PubMed ID: 16525420
[TBL] [Abstract][Full Text] [Related]
6. Transient T cell accumulation in lymph nodes and sustained lymphopenia in mice treated with FTY720.
Morris MA; Gibb DR; Picard F; Brinkmann V; Straume M; Ley K
Eur J Immunol; 2005 Dec; 35(12):3570-80. PubMed ID: 16285007
[TBL] [Abstract][Full Text] [Related]
7. FTY720 preferentially depletes naive T cells from peripheral and lymphoid organs.
Hofmann M; Brinkmann V; Zerwes HG
Int Immunopharmacol; 2006 Dec; 6(13-14):1902-10. PubMed ID: 17161343
[TBL] [Abstract][Full Text] [Related]
8. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors.
Chiba K
Pharmacol Ther; 2005 Dec; 108(3):308-19. PubMed ID: 15951022
[TBL] [Abstract][Full Text] [Related]
9. Involvement of sphingosine 1-phosphate (S1P) receptor type 1 and type 4 in migratory response of mouse T cells toward S1P.
Matsuyuki H; Maeda Y; Yano K; Sugahara K; Chiba K; Kohno T; Igarashi Y
Cell Mol Immunol; 2006 Dec; 3(6):429-37. PubMed ID: 17257496
[TBL] [Abstract][Full Text] [Related]
10. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists.
Mandala S; Hajdu R; Bergstrom J; Quackenbush E; Xie J; Milligan J; Thornton R; Shei GJ; Card D; Keohane C; Rosenbach M; Hale J; Lynch CL; Rupprecht K; Parsons W; Rosen H
Science; 2002 Apr; 296(5566):346-9. PubMed ID: 11923495
[TBL] [Abstract][Full Text] [Related]
11. Accumulation of fingolimod (FTY720) in lymphoid tissues contributes to prolonged efficacy.
Sensken SC; Bode C; Gräler MH
J Pharmacol Exp Ther; 2009 Mar; 328(3):963-9. PubMed ID: 19074680
[TBL] [Abstract][Full Text] [Related]
12. The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors.
Gräler MH; Goetzl EJ
FASEB J; 2004 Mar; 18(3):551-3. PubMed ID: 14715694
[TBL] [Abstract][Full Text] [Related]
13. Kruppel-like factor 2 regulates thymocyte and T-cell migration.
Carlson CM; Endrizzi BT; Wu J; Ding X; Weinreich MA; Walsh ER; Wani MA; Lingrel JB; Hogquist KA; Jameson SC
Nature; 2006 Jul; 442(7100):299-302. PubMed ID: 16855590
[TBL] [Abstract][Full Text] [Related]
14. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs.
Cyster JG
Annu Rev Immunol; 2005; 23():127-59. PubMed ID: 15771568
[TBL] [Abstract][Full Text] [Related]
15. Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes.
Forrest M; Sun SY; Hajdu R; Bergstrom J; Card D; Doherty G; Hale J; Keohane C; Meyers C; Milligan J; Mills S; Nomura N; Rosen H; Rosenbach M; Shei GJ; Singer II; Tian M; West S; White V; Xie J; Proia RL; Mandala S
J Pharmacol Exp Ther; 2004 May; 309(2):758-68. PubMed ID: 14747617
[TBL] [Abstract][Full Text] [Related]
16. The role of the lysophospholipid sphingosine 1-phosphate in immune cell biology.
von Wenckstern H; Zimmermann K; Kleuser B
Arch Immunol Ther Exp (Warsz); 2006; 54(4):239-51. PubMed ID: 16830220
[TBL] [Abstract][Full Text] [Related]
17. CD69 down-modulation and inhibition of thymic egress by short- and long-term selective chemical agonism of sphingosine 1-phosphate receptors.
Alfonso C; McHeyzer-Williams MG; Rosen H
Eur J Immunol; 2006 Jan; 36(1):149-59. PubMed ID: 16342326
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients.
Schwab SR; Pereira JP; Matloubian M; Xu Y; Huang Y; Cyster JG
Science; 2005 Sep; 309(5741):1735-9. PubMed ID: 16151014
[TBL] [Abstract][Full Text] [Related]
19. Sphingosine 1-phosphate receptor agonist FTY720-phosphate causes marginal zone B cell displacement.
Vora KA; Nichols E; Porter G; Cui Y; Keohane CA; Hajdu R; Hale J; Neway W; Zaller D; Mandala S
J Leukoc Biol; 2005 Aug; 78(2):471-80. PubMed ID: 15894589
[TBL] [Abstract][Full Text] [Related]
20. FTY720 modulates human oligodendrocyte progenitor process extension and survival.
Miron VE; Jung CG; Kim HJ; Kennedy TE; Soliven B; Antel JP
Ann Neurol; 2008 Jan; 63(1):61-71. PubMed ID: 17918267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
